Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 272 entries
View as:

Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00149240 Org: User:
Start: 01/31/05 End: 02/02/06 Due: 02/02/07

Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05543369 Org: User:
Start: 09/19/22 End: 03/10/23 Due: 03/10/24

Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients

Phase: N/A Priority: Normal
NCT ID: NCT02075606 Org: User:
Start: 05/31/14 End: 06/30/17 Due: 06/30/18

Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®

Phase: N/A Priority: Normal
NCT ID: NCT02353897 Org: User:
Start: 10/31/14 End: 07/31/16 Due: 07/31/17

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Phase: N/A Priority: Normal
NCT ID: NCT03569098 Org: User:
Start: 06/19/18 End: 05/22/20 Due: 05/22/21

Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02012036 Org: User:
Start: 07/31/13 End: 07/31/14 Due: 07/31/15

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02551991 Org: User:
Start: 10/19/15 End: 02/15/21 Due: 02/15/22

Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT00352989 Org: User:
Start: 07/31/06 End: 03/24/07 Due: 03/24/08

Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma

Phase: N/A Priority: Normal
NCT ID: NCT00690898 Org: User:
Start: 05/31/08 End: 02/29/12 Due: 02/28/13

BN80927 in Patients With Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01435096 Org: User:
Start: 11/30/04 End: 10/31/07 Due: 10/31/08

Validation of Patient Reported Outcome Measures for Use in Hallux Valgus

Phase: N/A Priority: Normal
NCT ID: NCT03846687 Org: User:
Start: 10/30/18 End: 01/15/20 Due: 01/15/21

Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00489255 Org: User:
Start: 05/31/07 End: 03/31/12 Due: 03/31/13

Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01018953 Org: User:
Start: 02/28/10 End: 01/31/11 Due: 01/31/12

A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).

Phase: N/A Priority: Normal
NCT ID: NCT05169775 Org: User:
Start: 03/02/22 End: 01/04/23 Due: 01/04/24

Post Marketing Surveillance Study of Dysport

Phase: N/A Priority: Normal
NCT ID: NCT00210431 Org: User:
Start: 10/31/04 End: 06/30/06 Due: 06/30/07

Dysport in the Treatment of Glabellar Lines in Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02450526 Org: User:
Start: 04/30/15 End: 09/06/17 Due: 09/06/18

A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

Phase: N/A Priority: Normal
NCT ID: NCT01942369 Org: User:
Start: 09/16/13 End: 07/13/18 Due: 07/13/19

Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT04003519 Org: User:
Start: 04/30/20 End: 12/30/23 Due: 12/30/24

Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.

Phase: N/A Priority: Normal
NCT ID: NCT05224349 Org: User:
Start: 05/09/22 End: 08/31/25 Due: 08/31/26

Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02704091 Org: User:
Start: 03/17/16 End: 04/08/19 Due: 04/08/20

Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01715129 Org: User:
Start: 01/31/13 End: 10/31/13 Due: 10/31/14

Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm

Phase: N/A Priority: Normal
NCT ID: NCT00234507 Org: User:
Start: 01/31/03 End: 05/25/04 Due: 05/25/05

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Phase: N/A Priority: Normal
NCT ID: NCT03017690 Org: User:
Start: 04/12/17 End: 05/30/18 Due: 05/30/19

Dysport® Adult Upper Limb Spasticity Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT01313312 Org: User:
Start: 11/30/11 End: 12/31/14 Due: 12/31/15

Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)

Phase: N/A Priority: Normal
NCT ID: NCT02969356 Org: User:
Start: 12/18/16 End: 07/31/18 Due: 07/31/19